There are over 7,000 known rare diseases, but fewer than 5% have effective treatments, let alone cures. The limited knowledge and consequent lack of treatments available for rare diseases is a major medical and pediatric emergency.
Rare diseases are collectively common:
The University of Oxford and Harrington Discovery Institute have formed a unique partnership combining world-leading strengths in research and therapeutics development, to form the Oxford-Harrington Rare Disease Centre. By leveraging our strengths and capabilities, the Oxford-Harrington Centre will advance knowledge leading to drug development in order to advance cures for rare disease.
Innovative discovery research and drug development programs will have access to cutting-edge scientific platforms complemented by extensive global partnerships. The Oxford-Harrington Rare Disease Centre will focus efforts on finding treatments and cures for rare diseases that fit within the following criteria:
Fund for Cures UK, Ltd. is Harrington Discovery Institute's UK charity and is the granting organization for the Centre.
Contact us to learn more about the Oxford-Harrington Rare Disease Centre.
Professor Matthew Wood
Director, Oxford-Harrington Rare Disease Centre; Professor of Neuroscience, University of Oxford
Mukesh Jain, MD
Co-Director, Oxford-Harrington Rare Disease Centre; Chief Scientific Officer, Harrington Discovery Institute
Sir John Bell, MD
Regius Professor of Medicine, University of Oxford
Georg Holländer, MD
Head of Department of Paediatrics, University of Oxford
Jonathan S. Stamler, MD
President, Harrington Discovery Institute
View our Rare Disease Day webinar.